Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 971-980 of 2859 for cancer

Edit search filters
  1. Analyses Of Metabolic Agents Following Brain Radiation

    Rochester, MN

  2. CBT Based Pain Management Program For The Treatment Of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) In Breast Cancer Survivors

    Jacksonville, FL

  3. BeWell360-CG Care Model: Health And Wellness Coaching To Support Caregivers Of Patients Living With Advanced Lung Cancers

    Jacksonville, FL

  4. A Drug-drug Interaction Study Of Avapritinib And Midazolam To Treat Unresectable Or Metastatic Gastrointestinal Stromal Tumors And Other Advanced Solid Tumors

    Jacksonville, FL

  5. Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors

    Jacksonville, FL, Rochester, MN

  6. S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

    Rochester, MN

  7. A Study To Evaluate The Safety, Tolerance And Anti-tumor Activity Of SAR442257 In Patients With Relapsed/Refractory Multiple Myeloma And Relapsed/Refractory Non-Hodgkin Lymphoma

    Rochester, MN

  8. A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. A Study Of Intratumoral Injection Of Autologous Dendritic Cells After High-Dose Conformal External Beam Radiotherapy In Patients With Unresectable Liver Cancer

    Rochester, MN

  10. Selinexor, Daratumumab, Carfilzomib And Dexamethasone For The Treatment Of High-Risk, Recurrent Or Refractory Multiple Myeloma

    Rochester, MN

.

Mayo Clinic Footer